Rosenblatt Maintains Buy on Calix, Raises Price Target to $45
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Mike Genovese maintains a Buy rating on Calix (NYSE:CALX) and raises the price target from $35 to $45.
July 24, 2024 | 11:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Mike Genovese maintains a Buy rating on Calix and raises the price target from $35 to $45.
The raised price target and maintained Buy rating from a reputable analyst are positive signals for investors, likely leading to increased investor confidence and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100